[HTML][HTML] Telomerase-targeted cancer immunotherapy

E Mizukoshi, S Kaneko - International Journal of Molecular Sciences, 2019 - mdpi.com
Telomerase, an enzyme responsible for the synthesis of telomeres, is activated in many
cancer cells and is involved in the maintenance of telomeres. The activity of telomerase …

[HTML][HTML] Role of telomeres and telomeric proteins in human malignancies and their therapeutic potential

SG Fernandes, R Dsouza, G Pandya, A Kirtonia… - Cancers, 2020 - mdpi.com
Telomeres are the ends of linear chromosomes comprised of repetitive nucleotide
sequences in humans. Telomeres preserve chromosomal stability and genomic integrity …

Trial Watch: Peptide vaccines in cancer therapy

F Aranda, E Vacchelli, A Eggermont, J Galon… - …, 2013 - Taylor & Francis
Throughout the past 3 decades, along with the recognition that the immune system not only
influences oncogenesis and tumor progression, but also determines how established …

[HTML][HTML] HNSCC: tumour antigens and their targeting by immunotherapy

A von Witzleben, C Wang, S Laban, N Savelyeva… - Cells, 2020 - mdpi.com
Head and neck squamous cell carcinomas (HNSCC) are a heterogeneous group of
malignant tumours typically caused by alcohol and tobacco consumption, although an …

Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001

EM Inderberg-Suso, S Trachsel, K Lislerud… - …, 2012 - Taylor & Francis
Understanding the basis of a successful clinical response after treatment with therapeutic
cancer vaccines is essential for the development of more efficacious therapy. After …

MHC class II tetramers

GT Nepom - The Journal of Immunology, 2012 - journals.aai.org
MHC class II tetramers have emerged as an important tool for characterization of the
specificity and phenotype of CD4 T cell immune responses, useful in a large variety of …

[HTML][HTML] Anti-cancer immunotherapies targeting telomerase

S Negrini, R De Palma, G Filaci - Cancers, 2020 - mdpi.com
Telomerase is a reverse transcriptase that maintains telomeres length, compensating for the
attrition of chromosomal ends that occurs during each replication cycle. Telomerase is …

Telomerase-based cancer therapeutics: a review on their clinical trials

N Relitti, AP Saraswati, S Federico… - Current Topics in …, 2020 - ingentaconnect.com
Telomeres are protective chromosomal ends that shield the chromosomes from DNA
damage, exonucleolytic degradation, recombination, and end-to-end fusion. Telomerase is …

Potential targets for pancreatic cancer immunotherapeutics

LF Dodson, WG Hawkins, P Goedegebuure - Immunotherapy, 2011 - Taylor & Francis
Pancreatic adenocarcinoma is the fourth leading cause of cancer death with an overall 5-
year survival of less than 5%. As there is ample evidence that pancreatic adenocarcinomas …

A prospective study of the efficacy of a combination of autologous dendritic cells, cytokine-induced killer cells, and chemotherapy in advanced non-small cell lung …

R Zhong, B Han, H Zhong - Tumor Biology, 2014 - Springer
Dendritic cells (DC) play a crucial role in the induction of an effective antitumor immune
response. Cytokine-induced killer (CIK) cells, a subset of T lymphocytes, have the capacity …